Internal · Financial Scenario Model

Raise, Runway & Team Scenarios

Preset:

Capital

What goes into the bank, and when. Runway headline is measured on the raise plus grants only, before any 2027 seed.

HQ canon band is 400K–500K. Investor sheet says ~775K. Slide to compare what each level buys.
SourceAmountMonthOn
Each lands at its own milestone month, not as one lump. Demo Fund and POCR are off by default: both are a pursuit (fall at the earliest, after G2M demo day), not committed. InnoVenture is equity (dilutive) through a lead. SBIR funds in 2027.
Seed and the 2027 grants are a separate round on top of the SAFE, not the SAFE minus anything. They only feed the funded-plan line.
Deferred until the fall raise, then paid as a lump at SAFE close. Ongoing counsel is in operating costs.
Team & salaries

Monthly cash salary per person. Set the start month (0 = Jul 2026) and headcount. Toggle a line off to see the leaner team. Reviewers can auto-scale with client volume below.

Role $/mo each Start mo Heads On
Operating costs (non-payroll)
Pricing & clients

Seeded so the client ramp reproduces the canonical revenue band (6K → 113K → 447K → ~1.3M). Adjust to test demand.

Share of recurring monitoring + certification revenue paid to the infrastructure partner. Set to 0 if GELI truly is near-zero marginal cost.
Per periodScans/moMonitor clientsCerts/yr

Cash balance over time

From today through 2029. The headline line is raise plus grants plus revenue, before the seed. If it crosses zero, that is when the lean phase runs out.

The J-curve: revenue overtaking cost

The investor story in one picture. Monthly revenue (teal) climbs past monthly cost (coral) as recurring monitoring compounds after the regulation lands. Where they cross is operating breakeven.

Revenue vs cost, by year

Revenue Total cost Net

Year-by-year summary

Team cost by role

Are we accounting for everything?

Recurring costs now modeled (all adjustable on the left). One-time items below are not yet in the monthly engine. Add them as a lump against the raise when you firm up quotes.

In the model now

  • Salaries (10 role lines) + payroll load
  • Variable model/compute per scan and per client
  • Infrastructure partner (GELI) revenue share
  • Insurance: E&O, D&O, cyber
  • Own accreditation + SOC2/ISO upkeep
  • Clinical / expert review panel
  • Legal, regulatory, accounting, tax, Carta, 409A
  • Sales & marketing, travel & events
  • Ongoing IP / patent prosecution
  • Deferred legal (Zach/Frederiksen) + back-pay at close
  • Grants + matching as cash inflows (offset burn)
  • Sales commission + contingency buffer

Confirm / add as one-time

  • Accreditation body application (one-time, can be large)
  • Patent filing / national-phase fees
  • Seed legal + 409A at the priced round
  • Recruiting fees for engineers / clinical
  • Gold-standard dataset build (Study III)
  • Security tooling for own SOC2 (Vanta-type)
  • Healthcare / benefits if not in the load %
  • Founder back-pay / deferred comp accrued pre-raise
  • GELI deal terms: confirm share vs flat vs equity
  • Capacity ratio: confirm against Study II load data

Planning figures from the founder's own model. Not financial advice. Confirm raise mechanics and the capacity ratio with G2M, counsel, and the Study II data. Built in Cowork, June 2026.